- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Age-Related Macular Degeneration in France
Total 474 results
-
Centre Hospitalier Intercommunal CreteilCompletedAge Related Macular DegenerationFrance
-
Centre Hospitalier Universitaire de NiceCompletedAge Related Macular DegenerationFrance
-
Hospices Civils de LyonCompleted
-
University Hospital, LimogesUnknownAge-related Macular Degeneration (AMD)France
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Centre de Recherche en Nutrition Humaine Rhone-AlpeCompletedAge Related Macular DegenerationFrance
-
Laboratoires TheaCompletedAge Related Macular DegenerationFrance
-
AffordanceDrescodeCompletedExudative Age-related Macular DegenerationFrance
-
Hospital St. Joseph, Marseille, FranceUnknownExudative Age-Related Macular DegenerationFrance
-
Hospices Civils de LyonRecruitingAge Related Macular DegenerationFrance
-
University Hospital, BordeauxCompletedNeovascular Age-related Macular Degeneration of All SubtypesFrance
-
Centre Hospitalier Universitaire, AmiensRecruitingAge-related Macular Degeneration (AMD)France
-
Hospices Civils de LyonNovartisCompletedStage 3 Age Related Macular Degeneration (AREDS Classification)France
-
Azienda Ospedaliera Universitaria Mater Domini,...RecruitingAge-Related Macular DegenerationFrance, Italy, Turkey, United Kingdom
-
ElsanAlcon ResearchRecruitingCataract | Macular Degeneration, Age RelatedFrance
-
AllerganMolecular Partners AGTerminatedWet Age-Related Macular DegenerationSwitzerland, France, Czech Republic
-
BayerCompletedWet Age-related Macular DegenerationCanada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
-
LumiThera, Inc.CompletedDry Age-related Macular DegenerationUnited Kingdom, Spain, France, Germany, Italy
-
Frank G. HolzRadboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaboratorsActive, not recruitingAge Related Macular Degeneration (AMD)Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
-
Fondation Ophtalmologique Adolphe de RothschildCompletedAge-related Macular DegenerationFrance
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
-
Hoffmann-La RocheRecruitingNeovascular Age-Related Macular DegenerationBelgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
-
Hoffmann-La RocheRecruitingNeovascular Age-related Macular Degeneration (nAMD)Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
Institut Pasteur de LilleRoquette Frères; SandersCompletedAge-related Macular DegenerationFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingAge-related Macular Degeneration (AMD)France
-
Novartis PharmaceuticalsCompletedNeovascular Age Related Macular DegenerationFrance
-
Evolucare TechnologiesAssistance Publique - Hôpitaux de Paris; Slb Pharma; BPIfranceRecruitingGlaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Age-related MaculopathyFrance
-
Bioeq GmbHCompletedAge-related Macular Degeneration (AMD)France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
-
Fondation Ophtalmologique Adolphe de RothschildCompletedLupus Erythematosus, Systemic | Age Related Macular Degeneration | Lupus ErythematosusFrance
-
Shanghai Henlius BiotechActive, not recruitingA Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMDAge Related Macular DegenerationUnited States, Singapore, Spain, Germany, Slovakia, China, Hungary, Australia, Bulgaria, Poland, Latvia, Czechia, France, Italy, Serbia
-
University Hospital, BordeauxCompletedAge-related Macular Degeneration | Elderly French PopulationFrance
-
Hospices Civils de LyonCompletedMacular Degeneration, Age-RelatedFrance
-
Notal Vision Ltd.WithdrawnAge Related Macular Degeneration | Choroidal NeovascularizationFrance
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
Opthea LimitedCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, France, Hungary, Israel, Italy, Latvia, Poland, Spain, United Kingdom
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
Opthea LimitedActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Philippines and more
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
-
ThromboGenicsCompletedExudative Age-Related Macular Degeneration | Focal Vitreomacular AdhesionUnited States, United Kingdom, Germany, France, Belgium, Italy
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationSpain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, China, Czechia, Denmark, France, Hungary, Israel, Italy, Latvia, Slovakia, United Kingdom
-
Genentech, Inc.RecruitingAge-Related Macular DegenerationFrance, Germany, Israel, United States, Australia, Puerto Rico, Italy
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationItaly, Canada, Switzerland, United States, United Kingdom, Austria, Belgium, Brazil, Czechia, Estonia, Latvia, Poland, Slovakia
-
Direction Centrale du Service de Santé des ArméesRecruitingAge-Related Macular Degeneration | Dry Eye SyndromesFrance